切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2008, Vol. 02 ›› Issue (04) : 436 -442. doi: 10.3877/cma.j.issn.1674-0807.2008.04.008

实验研究

小分子干扰RNA联合反义脱氧寡核苷酸靶向逆转人乳腺癌细胞MCF-7/ADR多药耐药的研究
魏军民1, 侯明1, 李丽珍1, 孔峰2, 高鹏3   
  1. 1.250012 济南,山东大学齐鲁医院肿瘤中心
    2.250012 济南,山东大学医学院分子生物学教研室
    3.250012 济南,山东大学医学院病理教研室
  • 收稿日期:2008-06-10 出版日期:2008-08-01

Reversal of multidrug resistance of human breast cancer MCF-7/ADR cells by small interfering RNAs combined with antisense oligodeoxyribonucleotides for inhibition of MDR1 gene expression

Jun-min WEI1, Ming HOU1, Li-zhen LI1, Peng GAO1   

  1. 1.Cancer Center,Qilu Hospital,Shandong University,Jinan 250012,China
  • Received:2008-06-10 Published:2008-08-01
引用本文:

魏军民, 侯明, 李丽珍, 孔峰, 高鹏. 小分子干扰RNA联合反义脱氧寡核苷酸靶向逆转人乳腺癌细胞MCF-7/ADR多药耐药的研究[J/OL]. 中华乳腺病杂志(电子版), 2008, 02(04): 436-442.

Jun-min WEI, Ming HOU, Li-zhen LI, Peng GAO. Reversal of multidrug resistance of human breast cancer MCF-7/ADR cells by small interfering RNAs combined with antisense oligodeoxyribonucleotides for inhibition of MDR1 gene expression[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2008, 02(04): 436-442.

目的

探讨针对多药耐药基因(MDR-1)的小分子干扰RNA(siRNAs)和反义脱氧寡核苷酸(asODNs)联合应用逆转人乳腺癌细胞MCF-7/ADR的作用效果。

方法

设计并合成针对MDR-1基因同一序列的siRNAs和asODNs及阴性对照siRNAs,采用转染试剂lipofectamineTM2000分别转染人乳腺癌耐药细胞MCF-7/ADR;利用RT-PCR检测MDR-1mRNA和Western blot检测MDR-1蛋白质的表达;采用罗丹明123外排实验检测P-gp的转运功能,MTT法检测MCF-7/ADR细胞对阿霉素的耐药逆转效果。

结果

siRNAs、asODNs、asODNs和siRNAs联合应用均能降低MDR-1 mRNA及其蛋白质表达,提高P-gp的转运功能,使细胞对阿霉素的敏感性明显恢复;asODNs和siRNAs联合应用效果明显提高;低浓度siRNAs(200 nmol/L)比高浓度asODNs(5μmol/L)的效果强。

结论

siRNAs、asODNs能有效逆转人乳腺癌细胞MCF-7/ADR的多药耐药,asODNs和siRNAs联合应用效果明显加强。

Objective

To study the effect of small interfering RNAs(siRNAs)combined with antisense oligodeoxyribonucleotides(asODNs),which targeted MDR1 gene,on reversing multidrug resistance of human breast cancer cell line MCF-7/ADR.

Methods

The siRNAs and asODNs which targeted the same sequences of MDR1 gene were designed and synthesized.Human breast cancer MCF-7/ADR cells were cultured and tranfected with asODNs,siRNAs+asODNs,siRNAs,and negative siRNAs using lipofectamineTM 2000,respectively.MDR-1mRNA was assayed by RT-PCR and the protein expression was detected by Western blotting.The function of P-glycoprotein(P-gp)was detected by rhodamine 123 retention and the resistant efficiency of MCF-7/ADR to ADM was determined by MTT method.

Results

The expressions of MDR-1mRNA and protein decreased significantly after transfection of asODNs,siRNAs+asODNs,and siRNAs respectively.The transporting function of P-gp increased and the resistance of MCF-7/ADR to ADM reversed significantly.The reversing effect increased significantly by siRNAs combined with asODNs.The inhibition effect of the siRNAs with lower concentration(200 nmol/L)was greater than that of asODNs with higher concentration(5μmol/L).

Conclusion

siRNAs and asODNs could reverse multidrug resistance of human breast cancer cell line MCF-7/ADR.The inhibition effect is increased significantly by siRNAs combined with asODNs.

图1 实验细胞MDR-1mRNA的表达 M:DL2000标记条带;A:耐药细胞;B:asODNs组;C:asODNs+siRNAs组;D:siRNAs组;E:阴性对照siRNAs组
图2 Western blot检测MDR-1蛋白的表达 A:耐药细胞;B:asODNs组;C:asODNs+siRNAs组;D:siRNAs组;E:阴性对照siRNAs组
[1]
Gottesman M M,Pastan I,Ambudkar SV.P-glycoprotein and multidrug resistanc.Curr Opin Genet Dev,1996,6:610-617.
[2]
Rye PD,Stigbrand T.Interfering with cancer:a brief outline of advances in RNA interference in oncology.Tumour Biol,2004,25:329-336.
[3]
Elbashir SM,Harborth J,Weber K,et al.Analysis of gene function in somatic mammalian cells using small interfering RNAs.Methods,2002,26:199-213.
[4]
Chan JY,Chu A C,Fung K P.Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene(mdr1)antisense RNA.Life Sci,2000,67:2117-2124.
[5]
Stuart D D,Kao G Y,Allen T M.A novel,long-circulating,and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1.Cancer Gene Therapy,2000,7:466-475.
[6]
Fire A,Xu S Q,Montgomery M K,et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.Nature,1998,391:806-811.
[7]
Hamilton A J,Baulcombe D C.A species of small antisense RNA in post-transcriptional gene silencing in plants.Science,1999,286:950-952.
[8]
Nieth C,Priebsch A,Stege A,et al.Modulation of the classical multidrug resistance(MDR)phenotype by RNA interference(RNAi).FEBSLett,2003,545:144-150.
[9]
Bertrand JR,Pottier M,Vekris A,et al.Comparison of antisense oligonucleotides and siRNAss in cell culture and in vivo.Biochem Biophys Res Commun,2002,296:1000-1004.
[10]
Lou T F,Gray C W,Gray D M.The reduction of Raf-1 protein by phosphorothioate ODNs and siRNAs targeted to the same two mRNA sequences.Oligonucleotides,2003,13:313-324.
[1] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[2] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[3] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[4] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[5] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[6] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[7] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[8] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[9] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[10] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[11] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[14] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[15] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
阅读次数
全文


摘要